Medicare Creates New Code g0328 for Immunoassay Fecal Occult Test

Why This Topic Matters

The update affects how Medicare screening services are reported and understood within preventive colorectal cancer testing. It also helps coding and billing professionals distinguish the article’s new Medicare coverage item from related CPT and HCPCS services discussed in the same context.

Article Sections

1. New Medicare screening code and fee schedule update

   Introduces the Medicare coverage change and the new screening code in the context of the 2004 fee schedule and national limit. It also notes the effective date and the general type of test involved.

2. Relationship to existing fecal occult blood testing and coverage

   Describes how the new screening option relates to existing fecal occult blood testing approaches and their Medicare coverage context. It also references associated diagnostic and screening services discussed alongside the change.

3. National coverage guidance and clinical rationale

   Summarizes Medicare’s national coverage activity and the broader technology assessment supporting coverage of the test. It also addresses the general policy rationale and implementation background.